A Trial of Zoledronic Acid in Patients With Myelofibrosis With Myeloid Metaplasia (MMM)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
In this trial, the question is addressed if zoledronic acid (Zometa, Novartis Pharma)could be of clinical benefit for patients with myelofibrosis and myeloid metaplasia (MMM).
Epistemonikos ID: 54b4f4f99abc8679cfae33f9ffcfc5232463b847
First added on: May 04, 2024